CEBPG

Across TCGA pan-cancer cohorts, CEBPG RNA differs between tumor and matched normal tissue in 12 of 18 cancer types tested, making tumor–normal expression one of CEBPG’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where CEBPG RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CEBPG is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

KIRC, HNSC, and STAD are the cancer types where CEBPG tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CEBPG RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Female	III,IV	+0.548	<.001	12	view →
HNSC	Male	IV	+0.881	<.001	11	view →
STAD	All	II,III,IV	+0.906	<.001	10	view →
THCA	Male	III,IV	−0.995	<.001	9	view →
LIHC	Male	All	+0.908	<.001	9	view →
BLCA	Male	IV	+0.712	<.001	8	view →
KIRP	All	II,III,IV	+0.584	.002	6	view →
LUSC	Male	All	+0.870	<.001	5	view →
ESCA	All	All	+1.047	<.001	4	view →
PAAD	All	All	+0.765	.001	4	view →
CHOL	Male	All	+0.843	.004	2	view →
UCEC	All	II,III,IV	+0.652	.042	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 12 lineages.

CEBPG–KIRC

Open the KIRC breakdown →